Save time and get answers to complex questions with AI chat
Abbvie humira patent cliff navigation success?When is the expected fda decision date for apotex's ruxolitinib resubmission?Is januvia still on the market?Dabrafenib patent expiration?What are the most memorable drug brands in oral factor b inhibitors? in united states
See the DrugPatentWatch profile for guaifenesin
Guaifenesin is an expectorant used to help loosen mucus and make coughing it up easier. It is not considered a blood thinner and does not have a known blood-thinning (anticoagulant or antiplatelet) effect.
Because guaifenesin is not classified as an anticoagulant or antiplatelet drug, it typically does not have the same bleeding-risk concerns as medicines like warfarin, apixaban, rivaroxaban, clopidogrel, or aspirin. That said, the main practical caution is that many “cold and cough” products combine guaifenesin with other ingredients (for example, decongestants or pain relievers). Some co-ingredients—especially NSAIDs (like ibuprofen/naproxen) or aspirin—can increase bleeding risk, so it’s important to check the full label, not just guaifenesin.
If you’re concerned about blood thinning, the ingredients that can matter most are ones with anticoagulant/antiplatelet or ulcer/bleeding risk, depending on the ingredient—especially aspirin or NSAIDs. Decongestants and expectorants are generally different in their effect profile than true blood thinners. If you share the exact product name (or a photo/text of the “Drug Facts” active ingredients), I can help identify whether any non-guaifenesin ingredient could affect bleeding risk.
Other Questions About Guaifenesin :